STOCK TITAN

Tenon Medical (TNON) director converts 10,732 RSUs into common stock

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tenon Medical, Inc. director Ivan Howard exercised 10,732 restricted stock units on July 31, 2026, converting them into 10,732 shares of common stock at $0.00 per share. The RSUs were fully converted, and his direct ownership increased to 19,194 common shares after the transaction.

Positive

  • None.

Negative

  • None.
Insider HOWARD IVAN
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F2 10,732 $0.00 $0.00
Exercise Common Stock F1 10,732 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 19,194 shares (Direct)
Footnotes (2)
  1. F1. Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.
  2. F2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
RSUs converted 10,732 units Restricted stock units converted into common stock on July 31, 2026
Common shares received 10,732 shares Shares of Tenon Medical common stock issued upon RSU conversion
Post-transaction holdings 19,194 shares Director Ivan Howard’s direct common stock holdings after the transaction
Exercise price $0.0000 per share Reported transaction price for common shares issued on RSU conversion
Exercise shares summary 10,732 shares Total shares involved in derivative exercise/conversion per transaction summary
Restricted Stock Units financial
"Represents conversion of 10,732 restricted stock units granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction code description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Tenon Medical (TNON) director Ivan Howard report?

Director Ivan Howard reported exercising 10,732 restricted stock units on July 31, 2026, which converted into 10,732 shares of common stock. This was reported as an exercise or conversion of a derivative security at a price of $0.00 per share.

How many Tenon Medical (TNON) shares does Ivan Howard hold after this Form 4?

Following the reported transactions, Ivan Howard directly holds 19,194 shares of Tenon Medical common stock. This reflects the addition of 10,732 shares received upon conversion of restricted stock units and the elimination of his corresponding RSU position.

What happened to the 10,732 restricted stock units reported by Tenon Medical (TNON)?

The 10,732 restricted stock units were converted into 10,732 shares of common stock. A footnote explains these RSUs were granted on October 13, 2025 and each unit represented a contingent right to receive one share of Tenon Medical common stock.

Was the Tenon Medical (TNON) insider transaction under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 affirmation box was not checked, so the transactions are not identified in this report as being made under a Rule 10b5-1 trading plan. No alternative pre-arranged trading arrangement is described in the footnotes.

What is the effective price per share in the Tenon Medical (TNON) RSU conversion?

The Form 4 reports a transaction price of $0.0000 per share for the 10,732 common shares issued upon RSU conversion. This reflects that the restricted stock units converted into common stock without additional cash consideration paid at exercise.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HOWARD IVAN

(Last)(First)(Middle)
104 COOPER COURT

(Street)
LOS GATOS CALIFORNIA 95032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)07/31/2026M10,732A$019,194D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)(2)07/31/2026M10,732 (1) (1)Common Stock10,732$00D
Explanation of Responses:
1. Represents conversion of 10,732 restricted stock units granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on July 31, 2026.
2. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
/s/ Ivan Howard08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)